Cancer Supportive Care Products Market: Lung Cancer Segment Projected to Remain Dominant over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016-2021
- REP-GB-2550
- 2016-12-23
- Category: Healthcare, Pharmaceuticals and Medical devices
- 212 Pages
- Format:
With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effects are increasing as well, which are addressed by cancer supportive care. The advent of technology in cancer supportive care has enabled to treat different signs and symptoms following the chemotherapy procedure, in addition to chemotherapy-induced vomiting, nausea, neutropenia, and anemia.
The global market for cancer supportive care products is currently thriving at a sound pace and is anticipated to see steady growth over the next few years. In 2016, the global cancer supportive care products market will possibly attain a value of over US$ 25.0 Bn, which may ramp up by 2021 end to US$ 29.87 Bn. Burgeoning need for effective supportive care products will continue to drive the market during 2016-2021.
Prominence of Cancer Incidences Spurs Adoption of Supportive Care
Pronounced incidences of different types of cancers will remain a primary factor driving the demand for quality supportive care. In addition, higher effectiveness of available anti-cancer drugs and a wide range of side-effects of various cancer treatments collectively support the market for cancer supportive care products on a global basis. The recent past has been observing increasing adoption of cancer supportive care drugs in order to deal with adverse effects of anti-cancer drugs. This will continue to provide a strong impetus to the demand for cancer supportive care products.
Increasing Availability of Supportive Care Products and Rising Healthcare Spending Favour Market Growth
Increasing awareness about the availability of supportive care products is expected to play a key role in promoting cancer supportive care products, especially in developing countries. Moreover, several governments have been proactively amplifying their healthcare expenditure, which is another driver the market growth. Consistent R&D activities related to cancer treatment and cancer supportive care are also foreseen to collectively fuel the market growth over the next few years.
New Product Launches Persist to Fuel Global Demand
Manufacturers are constantly focusing on developing innovative drugs and other supportive care products, such as vaccines; over 20 molecular entities have been introduced to the market recently with an aim to implement an additional, more effective therapy or a combination therapy. This is identified as a major booster to the market growth for the forecast period, 2016-2021.
Chemotherapy-induced Neutropenia Incidences Push Demand for Erythropoietin Stimulating Agents
The global cancer supportive care products market is segmented on the basis of several classes. Erythropoietin stimulating agents segment is predicted to represent the largest market share of over 26% by 2021 end. This growth is attributed to increasing prevalence of chemotherapy-induced neutropenia. Granulocyte colony-stimulating factors are expected to maintain the second largest segment, expanding at a CAGR of 4.2% over 2016-2021.
Lung Cancer Remains Leader in Terms of Disease Condition
On the basis of disease indication, there are nine segments, including lung cancer, breast cancer, prostate cancer, liver cancer, bladder cancer, leukemia, ovarian cancer, melanoma, and others. Lung cancer segment is projected to remain dominant over the forecast period with maximum market value share by 2021 end. However, breast cancer segment will witness a higher CAGR during 2016-2021.
APAC Projected for the Strongest Growth Rate, Followed by North America
By regional analysis, North America is foreseen to witness robust growth at a CAGR of 4.7% over 2016-2021, led by the U.S. Healthcare spending of the U.S. is estimated to rake in at an average rate of 5% over the next few years. This will be a strong factor bolstering the existing expenditure of cancer-inflicted patients across the country. Europe, the second most attractive market, will possibly capture around 22% share of the global market by 2021 end. Asia Pacific is likely to witness the highest CAGR, attributed to improving healthcare infrastructure and spending. The market in Latin America will gain a slight uptick, attributed to stable growth of the cancer supportive care products market in Brazil. MEA will also exhibit improved growth over the forecast period.
A few key players competing cancer supportive care products market are Novartis Ag., Johnson & Johnson, Hoffmann LA- Roche Ltd, and Amgen Inc. Some other notable companies include Baxter International Inc, APR Applied Pharma Science Research S.A., Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Kyowa Hakko Kirin Co Ltd., and Acacia Pharma Ltd.
Future Market Insights, through a newly published report, “Global Market Study on Cancer Supportive Care Products: Global Industry Analysis and Opportunity assessment 2016–2021”, offers a five-year forecast for the global cancer supportive care products market over 2016-2021. Our study demonstrates key market dynamics and developments across various regions of the country that are expected to influence the current status and future prospects of the global cancer supportive care products market. The primary objective of this report is to provide information on key drivers, restraints, opportunities, regulations, price, value chain analysis, and updates on developments in the global cancer supportive care products market, and conduct a quantitative as well as qualitative assessment of the market across various regional market segments.
Report Description
To understand and assess market opportunities and trends, the global cancer supportive care products market report is categorically split on the basis of drug class, disease condition, distribution channel, and geography. The report starts with a market overview and provides market definition and analysis of the value chain, pricing, cost structure, drivers, restraints, opportunities, trends, and regulations in the global cancer supportive care products market. The sections that follow include an analysis of the global cancer supportive care products market - by drug class, disease condition, distribution channel, and region. All these sections evaluate the qualitative and quantitative aspects of the global cancer supportive care products market on the basis of various factors affecting the market. To give a brief idea of revenue opportunities on segment-basis, the report also provides shipment (KT) data, absolute $ opportunity, and total incremental opportunity for each segment over the forecast period.
In the final section of the report, we have highlighted the global cancer supportive care products market structure and a detailed competition landscape with company market share and performance to provide report audiences with a dashboard view of key players operating in the global cancer supportive care products market.
Research Methodology
For market data analysis, we have considered 2015 as the base year, with market numbers estimated for 2016 and a comprehensive forecast made for 2017–2026. To calculate market size, the report considers the weighted average price, based on product type available across key regions of the country. The forecast assesses the total revenue as well as shipment (KT) of the global cancer supportive care products market. In order to provide an accurate forecast, we have started by sizing up the current market, which forms the basis of how the global cancer supportive care products market is expected to develop in the future. Critical market data – including the base number and segment splits – has been derived through in-depth secondary research. This data is then triangulated on the basis of different verticals, considering both supply side and demand side drivers and other dynamics of the various regional markets, along with primary interviews of manufacturers and industry experts operating in the global cancer supportive care products market.
Given the ever-fluctuating nature of the global economy, we have not only conducted forecasts in terms of CAGR, but have also analysed the market based on key parameters such as year-on-year (Y-o-Y) growth rate to understand market predictability and to identify the right opportunities across the global cancer supportive care products market. We have also analysed the different segments of the global cancer supportive care products market in terms of basis point share (BPS) to understand individual segment’s relative contribution to market growth. This detailed level of information is important for identifying the various key trends governing the global cancer supportive care products market. Another important feature of our report is an analysis of all the key segments in terms of absolute dollar opportunity, critical in evaluating the scope of opportunity that a provider can look to achieve, as well as to identify potential resources from a delivery perspective in the global cancer supportive care products market. The overall absolute dollar opportunity along with the segmental split is mentioned in the report. Further, to understand key market segments in terms of growth and performance, we have developed a market attractiveness index to help providers identify real market opportunities in the global cancer supportive care products market.
Cancer Supportive Care Products Market Reports - Table of Contents
1. Executive Summary
2. Research Methodology
3. Assumption & Acronyms Used
4. Market Overview
4.1. Parent Market Overview
4.2. Market Taxonomy & Market Definition
4.3. Global Cancer Supportive Care Products Market Size and Forecast
4.3.1. Introduction
4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021)
4.4. Global Cancer Supportive Care Products Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Trends
4.4.4. Opportunity
5. Regulations & PEST Analysis
6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class
6.1. Introduction
6.1.1. Introduction
6.1.2. Y-o-Y Growth Comparison, By Drug Class
6.1.3. BPS Analysis, By Drug Class
6.1.3.1. Nonsteroidal Anti-inflammatory Drugs
6.1.3.2. Anti-infective
6.1.3.3. Anti-emetics
6.1.3.4. Monoclonal Antibodies
6.1.3.5. Erythropoietin Stimulating Agents
6.1.3.6. Opioid Analgesics
6.1.3.7. Bisphosphonates
6.1.3.8. Granulocyte Colony Stimulating Factor
6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
7. Global Cancer Supportive Care Products Market Analysis and Forecast By Indication
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Indication
7.1.2. BPS Analysis, By Indication
7.1.2.1. Lung Cancer
7.1.2.2. Breast Cancer
7.1.2.3. Prostate Cancer
7.1.2.4. Liver Cancer
7.1.2.5. Bladder Cancer
7.1.2.6. Leukaemia
7.1.2.7. Ovarian Cancer
7.1.2.8. Melanoma
7.1.2.9. Other Cancer
7.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication
8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution Channel
8.1. Introduction
8.1.1. Y-o-Y Growth Comparison, By Distribution Channel
8.1.2. BPS Analysis, By Distribution Channel
8.1.2.1. Hospital Pharmacies
8.1.2.2. Retail Pharmacies
8.1.2.3. Compounding Pharmacies
8.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
9. Global Cancer Supportive Care Products Market Analysis and Forecast By Region
9.1. Introduction
9.1.1. Y-o-Y Growth Comparison, By Region
9.1.2. BPS Analysis, By Region
9.1.2.1. North America
9.1.2.2. Latin America
9.1.2.3. Europe
9.1.2.4. Asia Pacific
9.1.2.5. MEA
9.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Region
10. North America Cancer Supportive Care Products Market Analysis
10.1. Introduction
10.2. U.S.
10.2.1. Market Value & Y-o-Y Growth
10.2.2. Absolute $ Opportunity
10.3. Canada
10.3.1. Market Value & Y-o-Y Growth
10.3.2. Absolute $ Opportunity
10.4. North America Cancer Supportive Care Products Market Value By Drug Class
10.5. North America Cancer Supportive Care Products Market Value By Disease Indication
10.6. North America Cancer Supportive Care Products Market Value By Distribution Channel
10.7. North America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
10.8. North America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
10.9. North America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
10.10. North America Cancer Supportive Care Products Market Attractiveness Analysis By Country
11. Latin America Cancer Supportive Care Products Market Analysis
11.1. Introduction
11.2. Argentina
11.2.1. Market Value & Y-o-Y Growth
11.2.2. Absolute $ Opportunity
11.3. Brazil
11.3.1. Market Value & Y-o-Y Growth
11.3.2. Absolute $ Opportunity
11.4. Mexico
11.4.1. Market Value & Y-o-Y Growth
11.4.2. Absolute $ Opportunity
11.5. Rest of Latin America
11.5.1. Market Value & Y-o-Y Growth
11.5.2. Absolute $ Opportunity
11.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
11.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
11.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
11.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
11.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
11.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
11.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country
12. Latin America Cancer Supportive Care Products Market Analysis
12.1. Introduction
12.2. Argentina
12.2.1. Market Value & Y-o-Y Growth
12.2.2. Absolute $ Opportunity
12.3. Brazil
12.3.1. Market Value & Y-o-Y Growth
12.3.2. Absolute $ Opportunity
12.4. Mexico
12.4.1. Market Value & Y-o-Y Growth
12.4.2. Absolute $ Opportunity
12.5. Rest of Latin America
12.5.1. Market Value & Y-o-Y Growth
12.5.2. Absolute $ Opportunity
12.6. Latin America Cancer Supportive Care Products Market Value By Drug Class
12.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication
12.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel
12.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
12.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication
12.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
12.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country
13. Europe Cancer Supportive Care Products Market Analysis
13.1. Introduction
13.2. Germany
13.2.1. Market Value & Y-o-Y Growth
13.2.2. Absolute $ Opportunity
13.3. U.K.
13.3.1. Market Value & Y-o-Y Growth
13.3.2. Absolute $ Opportunity
13.4. France
13.4.1. Market Value & Y-o-Y Growth
13.4.2. Absolute $ Opportunity
13.5. Italy
13.5.1. Market Value & Y-o-Y Growth
13.5.2. Absolute $ Opportunity
13.6. Spain
13.6.1. Market Value & Y-o-Y Growth
13.6.2. Absolute $ Opportunity
13.7. Nordic
13.7.1. Market Value & Y-o-Y Growth
13.7.2. Absolute $ Opportunity
13.8. Russia
13.8.1. Market Value & Y-o-Y Growth
13.8.2. Absolute $ Opportunity
13.9. Rest of Europe
13.9.1. Market Value & Y-o-Y Growth
13.9.2. Absolute $ Opportunity.
13.10. Europe Cancer Supportive Care Products Market Value By Drug Class
13.11. Europe Cancer Supportive Care Products Market Value By Disease Indication
13.12. Europe Cancer Supportive Care Products Market Value By Distribution Channel
13.13. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
13.14. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication
13.15. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
13.16. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country
14. Asia Pacific Cancer Supportive Care Products Market Analysis
14.1. Introduction
14.2. Greater China
14.2.1. Market Value & Y-o-Y Growth
14.2.2. Absolute $ Opportunity
14.3. India
14.3.1. Market Value & Y-o-Y Growth
14.3.2. Absolute $ Opportunity
14.4. Japan
14.4.1. Market Value & Y-o-Y Growth
14.4.2. Absolute $ Opportunity
14.5. Australia and New Zealand
14.5.1. Market Value & Y-o-Y Growth
14.5.2. Absolute $ Opportunity
14.6. Rest of APAC
14.6.1. Market Value & Y-o-Y Growth
14.6.2. Absolute $ Opportunity
14.7. Asia Pacific Cancer Supportive Care Products Market Value By Drug Class
14.8. Asia Pacific Cancer Supportive Care Products Market Value By Disease Indication
14.9. Asia Pacific Cancer Supportive Care Products Market Value By Distribution Channel
14.10. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
14.11. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Indication
14.12. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
14.13. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Country
15. MEA Cancer Supportive Care Products Market Analysis
15.1. Introduction
15.2. GCC
15.2.1. Market Value & Y-o-Y Growth
15.2.2. Absolute $ Opportunity
15.3. South Africa
15.3.1. Market Value & Y-o-Y Growth
15.3.2. Absolute $ Opportunity
15.4. Rest of MEA
15.4.1. Market Value & Y-o-Y Growth
15.4.2. Absolute $ Opportunity
15.5. MEA Cancer Supportive Care Products Market Value By Drug Class
15.6. MEA Cancer Supportive Care Products Market Value By Disease Indication
15.7. MEA Cancer Supportive Care Products Market Value By Distribution Channel
15.8. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class
15.9. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication
15.10. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel
15.11. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country
16. Competitive Landscape
16.1. Amgen Inc.
16.2. Johnson & Johnson Private Ltd.
16.3. Novartis AG
16.4. Baxter International Inc
16.5. Hoffmann-La Roche Ltd.
16.6. Fagron Group BV
16.7. Teva Pharmaceutical Industries Ltd.
Cancer Supportive Care Products Market Reports - List of Tables
Table 01: Global Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 02: Global Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 03: Global Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 04: North America Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 05: North America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 06: North America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 07: Latin America Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 08: Latin America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 09: Latin America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 10: Europe Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 11: Europe Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 12: Europe Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 13: APAC Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 14: APAC Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 15: APAC Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Table 16: MEA Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn)
Table 17: MEA Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn)
Table 18: MEA Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn)
Cancer Supportive Care Products Market Reports - List of Figures
Figure 01: Global Oncology Drug Market Value (US$ Mn) 2014–2021
Figure 02: Global Cancer Supportive Care Drug Market – Scenario Forecast, 2015–2021 (US$ Mn)
Figure 03: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 04: Global Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 05: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Drug Class, 2015–2021
Figure 06: Cancer Supportive Care Products Market Value Share & BPS Analysis By Drug Class, 2015 & 2021
Figure 07: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 08: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Nonsteroidal Anti-inflammatory Drugs, 2015–2021
Figure 09: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti-infective, 2015–2021
Figure 10: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti-infective, 2015–2021
Figure 11: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti-emetics, 2015–2021
Figure 12: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti-emetics, 2015–2021
Figure 13: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) Monoclonal Antibodies, 2015–2021
Figure 14: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Monoclonal Antibody, 2015–2021
Figure 15: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Erythropoietin Stimulating Agent, 2015–2021
Figure 16: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Erythropoietin Stimulating Agent, 2015–2021
Figure 17: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Opioid Analgesics, 2015–2021
Figure 18: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Opioid Analgesics, 2015–2021
Figure 19: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bisphosphonates, 2015–2021
Figure 20: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Bisphosphonates, 2015–2021
Figure 21: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Granulocyte Colony Stimulating Factor, 2015–2021
Figure 22: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Granulocyte Colony Stimulating Factor, 2015–2021
Figure 23: Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class, 2015–2021
Figure 24: Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 25: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Indication, 2015–2021
Figure 26: Cancer Supportive Care Products Market Value Share & BPS Analysis by Indication, 2015 & 2021
Figure 27: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Lung Cancer, 2015–2021
Figure 28: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Lung Cancer, 2015–2021
Figure 29: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Breast Cancer, 2015–2021
Figure 30: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Breast Cancer, 2015–2021
Figure 31: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Prostate Cancer, 2015–2021
Figure 32: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Prostate Cancer, 2015–2021
Figure 33: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Liver Cancer, 2015–2021
Figure 34: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Liver Cancer, 2015–2021
Figure 35: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bladder Cancer, 2015–2021
Figure 36: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Bladder Cancer, 2015–2021
Figure 37: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Leukaemia, 2015–2021
Figure 38: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Leukaemia, 2015–2021
Figure 39: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Ovarian Cancer, 2015–2021
Figure 40: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Ovarian Cancer, 2015–2021
Figure 41: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Melanoma, 2015–2021
Figure 42: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Melanoma, 2015–2021
Figure 43: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Other Cancer, 2015–2021
Figure 44: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Other Cancer 2015–2021
Figure 45: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Distribution Channel, 2015–2021
Figure 46: Cancer Supportive Care Products Market Value Share & BPS Analysis by Distribution Channel, 2015 & 2021
Figure 47: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Hospital Pharmacies, 2015–2021
Figure 48: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Hospital Pharmacies, 2015–2021
Figure 49: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Retail Pharmacies, 2015–2021
Figure 50: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Retail Pharmacies, 2015–2021
Figure 51: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Compounding Pharmacies, 2015–2021
Figure 52: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Compounding Pharmacies, 2015–2021
Figure 53: Global Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 54: Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Region, 2015–2021
Figure 55: Cancer Supportive Care Products Market Value Share & BPS Analysis By Region, 2015 & 2021
Figure 56: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for North America Region, 2015–2021
Figure 57: Global Cancer Supportive Care Products Market Absolute $ Opportunity for North America Region, 2015–2021
Figure 58: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Latin America Region, 2015–2021
Figure 59: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Latin America Region, 2015–2021
Figure 60: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Europe Region, 2015–2021
Figure 61: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Europe Region, 2015–2021
Figure 62: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Asia Pacific Region, 2015–2021
Figure 63: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Asia Pacific Region, 2015–2021
Figure 64: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Middle East and Africa Region, 2015–2021
Figure 65: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Middle East and Africa Region, 2015–2021
Figure 66: Global Cancer Supportive Care Products Market Attractiveness Analysis by Region, 2015–2021
Figure 67: U.S. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 68: U.S. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 69: Canada Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 70: Canada Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 71: North America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 72: North America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021
Figure 73: North America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 74: North America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021
Figure 75: Argentina Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) , 2015–2021
Figure 76: Argentina Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 77: Brazil Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 78: Brazil Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 79: Mexico Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 80: Mexico Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 81: Rest of Latin America Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 82: Rest of Latin America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 83: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 84: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021
Figure 85: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021
Figure 86: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021
Figure 87: Germany Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 88: Germany Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 89: U.K. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 90: U.K. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 91: France Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 92: France Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 93: Italy Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 94: Italy Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 95: Spain Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 96: Spain Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 97: Nordic Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 98: Nordic Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 99: Russia Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 100: Russia Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 101: Rest Of Europe Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 102: Rest Of Europe Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 103: Europe Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 104: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 105: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 106: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021
Figure 107: Greater China Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 108: Greater China Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 109: India Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 110: India Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 111: Japan Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 112: Japan Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 113: Australia and New Zealand Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 114: Australia and New Zealand Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 115: Rest of APAC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 116: Rest of APAC Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 117: APAC Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 118: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 119: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 120: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021
Figure 121: GCC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 122: GCC America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 123: South Africa Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 124: South Africa Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 125: Rest Of MEA Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021
Figure 126: Rest Of MEA Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021
Figure 127: MEA Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021
Figure 128: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021
Figure 129: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021
Figure 130: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021